Skip to main content
Erschienen in: Strahlentherapie und Onkologie 3/2016

01.03.2016 | Original Article

Temporal changes in tumor oxygenation and perfusion upon normo- and hyperbaric inspiratory hyperoxia

verfasst von: Prof. Dr. med. Oliver Thews, Prof. Dr. med. Peter Vaupel

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Inspiratory hyperoxia under hyperbaric conditions has been shown to effectively reduce tumor hypoxia and to improve radiosensitivity. However, applying irradiation (RT) under hyperbaric conditions is technically difficult in the clinical setting since RT after decompression may be effective only if tumor pO2 remains elevated for a certain period of time. The aim of the present study was to analyze the time course of tumor oxygenation and perfusion during and after hyperbaric hyperoxia.

Materials and methods

Tumor oxygenation, red blood cell (RBC) flux for perfusion monitoring, and vascular resistance were assessed continuously in experimental rat DS-sarcomas by polarographic catheter electrodes and laser Doppler flowmetry at 1 and 2 atm (bar) of environmental pressure during breathing of pure O2 or carbogen (95 % O2 + 5 % CO2).

Results

During room air breathing, the tumor pO2 followed very rapidly within a few minutes the change of the ambient pressure during compression or decompression. With O2 breathing under hyperbaric conditions, the tumor pO2 increased more than expected based on the rise of the environmental pressure, although the time course was comparably rapid. Breathing carbogen, the tumor pO2 followed with a slight delay of the pressure change, and within 10 min after decompression the baseline values were reached again. RBC flux increased during carbogen breathing but remained almost constant with pure O2, indicating a vasodilation (decrease in vascular resistance) with carbogen but a vasoconstriction (increase in vascular resistance) with O2 during hyperbaric conditions.

Conclusion

Since the tumor pO2 directly followed the environmental pressure, teletherapy after hyperbaric conditions does not seem to be promising as the pO2 reaches baseline values again within 5–10 min after decompression.
Literatur
1.
Zurück zum Zitat Gray LH, Conger AD, Ebert M et al (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638–648CrossRefPubMed Gray LH, Conger AD, Ebert M et al (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638–648CrossRefPubMed
2.
Zurück zum Zitat Hall EJ, Giaccia AJ (2011) Radiobiology for the Radiologist. Lippincott Williams & Wilkins, Philadelphia Hall EJ, Giaccia AJ (2011) Radiobiology for the Radiologist. Lippincott Williams & Wilkins, Philadelphia
3.
Zurück zum Zitat Höckel M, Schlenger K, Mitze M et al (1996) Hypoxia and radiation response in human tumors. Sem Radiat Oncol 6:3–9CrossRef Höckel M, Schlenger K, Mitze M et al (1996) Hypoxia and radiation response in human tumors. Sem Radiat Oncol 6:3–9CrossRef
4.
Zurück zum Zitat Nordsmark M, Bentzen SM, Rudat V et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18–24CrossRefPubMed Nordsmark M, Bentzen SM, Rudat V et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18–24CrossRefPubMed
5.
Zurück zum Zitat Thews O, Vaupel P (2015) Spatial oxygenation profiles in tumors during normo- and hyperbaric hyperoxia. Strahlenther Onkol. doi:10.1007/s00066-015-0867-6 Thews O, Vaupel P (2015) Spatial oxygenation profiles in tumors during normo- and hyperbaric hyperoxia. Strahlenther Onkol. doi:10.1007/s00066-015-0867-6
6.
Zurück zum Zitat Siemann DW, Horsman MR (2015) Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacol Ther 153:107–124CrossRefPubMed Siemann DW, Horsman MR (2015) Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacol Ther 153:107–124CrossRefPubMed
7.
Zurück zum Zitat Kruuv JA, Inch WR, McCredie JA (1967) Blood flow and oxygenation of tumors in mice. I. Effects of breathing gases containing carbon dioxide at atmospheric pressure. Cancer 20:51–59CrossRefPubMed Kruuv JA, Inch WR, McCredie JA (1967) Blood flow and oxygenation of tumors in mice. I. Effects of breathing gases containing carbon dioxide at atmospheric pressure. Cancer 20:51–59CrossRefPubMed
8.
Zurück zum Zitat Suit HD, Marshall N, Woerner D (1972) Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma. Cancer 30:1154–1158CrossRefPubMed Suit HD, Marshall N, Woerner D (1972) Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma. Cancer 30:1154–1158CrossRefPubMed
9.
Zurück zum Zitat Thews O, Kelleher DK, Vaupel P (2002) Dynamics of tumor oxygenation and red blood cell flux in response to inspiratory hyperoxia combined with different levels of inspiratory hypercapnia. Radiother Oncol 62:77–85CrossRefPubMed Thews O, Kelleher DK, Vaupel P (2002) Dynamics of tumor oxygenation and red blood cell flux in response to inspiratory hyperoxia combined with different levels of inspiratory hypercapnia. Radiother Oncol 62:77–85CrossRefPubMed
10.
Zurück zum Zitat Hoskin PJ, Rojas AM, Saunders MI et al (2009) Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial. Radiother Oncol 91:120–125CrossRefPubMed Hoskin PJ, Rojas AM, Saunders MI et al (2009) Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial. Radiother Oncol 91:120–125CrossRefPubMed
11.
Zurück zum Zitat Janssens GO, van Bockel LW, Doornaert PA et al (2014) Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: results of the phase 3 ARCON trial. Eur J Cancer 50:1112–1119CrossRefPubMed Janssens GO, van Bockel LW, Doornaert PA et al (2014) Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: results of the phase 3 ARCON trial. Eur J Cancer 50:1112–1119CrossRefPubMed
12.
Zurück zum Zitat Rademakers SE, Hoogsteen IJ, Rijken PF et al (2015) Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial. Head Neck 37:171–176CrossRefPubMed Rademakers SE, Hoogsteen IJ, Rijken PF et al (2015) Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial. Head Neck 37:171–176CrossRefPubMed
13.
Zurück zum Zitat Cater DB, Schoeniger EL, Watkinson DA (1962) Effect on oxygen tension of tumours of breathing oxygen at high pressures. Lancet 280:381–383CrossRef Cater DB, Schoeniger EL, Watkinson DA (1962) Effect on oxygen tension of tumours of breathing oxygen at high pressures. Lancet 280:381–383CrossRef
14.
Zurück zum Zitat Mueller-Klieser W, Vaupel P, Manz R (1983) Tumour oxygenation under normobaric and hyperbaric conditions. Br J Radiol 56:559–564CrossRefPubMed Mueller-Klieser W, Vaupel P, Manz R (1983) Tumour oxygenation under normobaric and hyperbaric conditions. Br J Radiol 56:559–564CrossRefPubMed
15.
Zurück zum Zitat Alagoz T, Buller RE, Anderson B et al (1995) Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 75:2313–2322CrossRefPubMed Alagoz T, Buller RE, Anderson B et al (1995) Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 75:2313–2322CrossRefPubMed
16.
Zurück zum Zitat Brizel DM, Hage WD, Dodge RK et al (1997) Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide. Radiat Res 147:715–720CrossRefPubMed Brizel DM, Hage WD, Dodge RK et al (1997) Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide. Radiat Res 147:715–720CrossRefPubMed
17.
Zurück zum Zitat Hartmann KA, van der Kleij AJ, Carl UM et al (2001) Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H. Int J Radiat Oncol Biol Phys 51:1037–1044CrossRefPubMed Hartmann KA, van der Kleij AJ, Carl UM et al (2001) Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H. Int J Radiat Oncol Biol Phys 51:1037–1044CrossRefPubMed
18.
Zurück zum Zitat Rojas A, Stewart FA, Smith KA et al (1987) Effect of anemia on tumor radiosensitivity under normo- and hyperbaric conditions. Int J Radiat Oncol Biol Phys 13:1681–1689CrossRefPubMed Rojas A, Stewart FA, Smith KA et al (1987) Effect of anemia on tumor radiosensitivity under normo- and hyperbaric conditions. Int J Radiat Oncol Biol Phys 13:1681–1689CrossRefPubMed
19.
Zurück zum Zitat Cade IS, McEwen JB (1978) Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964–1976. Clin Radiol 29:333–338CrossRefPubMed Cade IS, McEwen JB (1978) Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964–1976. Clin Radiol 29:333–338CrossRefPubMed
20.
Zurück zum Zitat Sause WT, Plenk HP (1979) Radiation therapy of head and neck tumors: a randomized study of treatment in air vs. treatment in hyperbaric oxygen. Int J Radiat Oncol Biol Phys 5:1833–1836CrossRefPubMed Sause WT, Plenk HP (1979) Radiation therapy of head and neck tumors: a randomized study of treatment in air vs. treatment in hyperbaric oxygen. Int J Radiat Oncol Biol Phys 5:1833–1836CrossRefPubMed
21.
Zurück zum Zitat Hoskin PJ, Saunders MI, Dische S (1999) Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer 86:1322–1328CrossRefPubMed Hoskin PJ, Saunders MI, Dische S (1999) Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer 86:1322–1328CrossRefPubMed
22.
Zurück zum Zitat Mayer R, Hamilton-Farrell MR, van der Kleij AJ et al (2005) Hyperbaric oxygen and radiotherapy. Strahlenther Onkol 181:113–123CrossRefPubMed Mayer R, Hamilton-Farrell MR, van der Kleij AJ et al (2005) Hyperbaric oxygen and radiotherapy. Strahlenther Onkol 181:113–123CrossRefPubMed
23.
Zurück zum Zitat Overgaard J (2011) Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck—a systematic review and meta-analysis. Radiother Oncol 100:22–32CrossRefPubMed Overgaard J (2011) Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck—a systematic review and meta-analysis. Radiother Oncol 100:22–32CrossRefPubMed
24.
Zurück zum Zitat Sealy R (1991) Hyperbaric oxygen in the radiation treatment of head and neck cancers. Radiother Oncol 20:75–79CrossRefPubMed Sealy R (1991) Hyperbaric oxygen in the radiation treatment of head and neck cancers. Radiother Oncol 20:75–79CrossRefPubMed
25.
Zurück zum Zitat Beppu T, Kamada K, Nakamura R et al (2003) A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas. J Neurooncol 61:161–170CrossRefPubMed Beppu T, Kamada K, Nakamura R et al (2003) A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas. J Neurooncol 61:161–170CrossRefPubMed
26.
Zurück zum Zitat Kohshi K, Kinoshita Y, Terashima H et al (1996) Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. J Cancer Res Clin Oncol 122:676–678CrossRefPubMed Kohshi K, Kinoshita Y, Terashima H et al (1996) Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. J Cancer Res Clin Oncol 122:676–678CrossRefPubMed
27.
28.
Zurück zum Zitat Kinoshita Y, Kohshi K, Kunugita N et al (2000) Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer 82:88–92PubMedCentralCrossRefPubMed Kinoshita Y, Kohshi K, Kunugita N et al (2000) Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer 82:88–92PubMedCentralCrossRefPubMed
29.
30.
Zurück zum Zitat Kelleher DK, Engel T, Vaupel PW (1995) Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 11:241–255CrossRefPubMed Kelleher DK, Engel T, Vaupel PW (1995) Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 11:241–255CrossRefPubMed
31.
Zurück zum Zitat Kelleher DK, Thews O, Vaupel P (1998) Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration. Int J Radiat Oncol Biol Phys 42:861–864CrossRefPubMed Kelleher DK, Thews O, Vaupel P (1998) Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration. Int J Radiat Oncol Biol Phys 42:861–864CrossRefPubMed
32.
Zurück zum Zitat Gerweck LE, Hetzel FW (1995) PO2 in irradiated versus nonirradiated tumors of mice breathing oxygen at normal and elevated pressure. Int J Radiat Oncol Biol Phys 32:695–701CrossRefPubMed Gerweck LE, Hetzel FW (1995) PO2 in irradiated versus nonirradiated tumors of mice breathing oxygen at normal and elevated pressure. Int J Radiat Oncol Biol Phys 32:695–701CrossRefPubMed
33.
Zurück zum Zitat Kruuv J, Inch WR, McCredie JA (1967) Effects of breathing gases containing oxygen and carbon dioxide at 1 and 3 atmospheres pressure on blood flow and oxygenation of tumors. Can J Physiol Pharmacol 45:49–56CrossRefPubMed Kruuv J, Inch WR, McCredie JA (1967) Effects of breathing gases containing oxygen and carbon dioxide at 1 and 3 atmospheres pressure on blood flow and oxygenation of tumors. Can J Physiol Pharmacol 45:49–56CrossRefPubMed
34.
Zurück zum Zitat Matsumoto K, Bernardo M, Subramanian S et al (2006) MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med 56:240–246CrossRefPubMed Matsumoto K, Bernardo M, Subramanian S et al (2006) MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med 56:240–246CrossRefPubMed
35.
Zurück zum Zitat Boron WF, Boulpaep EL (2012) Medical Physiology. Saunders, Elsevier, Philadelphia Boron WF, Boulpaep EL (2012) Medical Physiology. Saunders, Elsevier, Philadelphia
36.
Zurück zum Zitat Modun D, Krnic M, Vukovic J et al (2012) Plasma nitrite concentration decreases after hyperoxia-induced oxidative stress in healthy humans. Clin Physiol Funct Imaging 32:404–408CrossRefPubMed Modun D, Krnic M, Vukovic J et al (2012) Plasma nitrite concentration decreases after hyperoxia-induced oxidative stress in healthy humans. Clin Physiol Funct Imaging 32:404–408CrossRefPubMed
37.
Zurück zum Zitat Sjöberg F, Singer M (2013) The medical use of oxygen: a time for critical reappraisal. J Intern Med 274:505–528CrossRefPubMed Sjöberg F, Singer M (2013) The medical use of oxygen: a time for critical reappraisal. J Intern Med 274:505–528CrossRefPubMed
38.
Zurück zum Zitat Morton GC, Hoskin PJ (2013) Brachytherapy: current status and future strategies—can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol (R Coll Radiol) 25:474–482CrossRef Morton GC, Hoskin PJ (2013) Brachytherapy: current status and future strategies—can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol (R Coll Radiol) 25:474–482CrossRef
39.
Zurück zum Zitat Hoskin P (2008) High dose rate brachytherapy for prostate cancer. Cancer Radiother 12:512–514CrossRefPubMed Hoskin P (2008) High dose rate brachytherapy for prostate cancer. Cancer Radiother 12:512–514CrossRefPubMed
Metadaten
Titel
Temporal changes in tumor oxygenation and perfusion upon normo- and hyperbaric inspiratory hyperoxia
verfasst von
Prof. Dr. med. Oliver Thews
Prof. Dr. med. Peter Vaupel
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 3/2016
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-015-0916-1

Weitere Artikel der Ausgabe 3/2016

Strahlentherapie und Onkologie 3/2016 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.